Takeda Pharmaceutical Company Limited (TKPHF) 은(는) 상장 기업입니다 헬스케어 섹터의 Drug Manufacturers - Specialty & Generic 산업에서 운영. 본사 소재지는 Tokyo, 일본. 현재 CEO는 Christophe Weber.
TKPHF 을(를) 보유 IPO 날짜 2008-06-25, 49,281 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $54.53B.
Takeda Pharmaceutical Company Limited is a global pharmaceutical company headquartered in Tokyo, Japan, with operations across Japan, the United States, Europe, and other international markets. Founded in 1781, the company engages in the research, development, manufacture, and marketing of pharmaceutical products across five core therapeutic areas: gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Takeda markets numerous branded pharmaceutical products including Entyvio, Velcade, Adcetris, and Takhzyro, among others, and maintains an extensive network of collaborations, licensing agreements, and strategic alliances with leading research institutions and biotechnology companies worldwide to support its innovation pipeline.
